Companies / NovaBridge Biosciences
NovaBridge Biosciences
Nasdaq: NBPCIK 1778016ROCKVILLE, MD
Financials ยท FY2023
Ownership
265.4M shares outstanding
Ownership
| Institutions | 11.87% | 31,505,475 |
| Public float | 88.13% | 233,872,416 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 16
View all โ| Insider | % of shares | Shares |
|---|---|---|
Au Chun Kwok AlanDirector | โ | โ |
Cao Sean WuxiongSee Remarks ยท Director | โ | โ |
Chu Denny Hsueh WenSee Remarks | โ | โ |
Cunningham EmmettDirector | โ | โ |
Dennis Phillip AndrewChief Medical Officer | โ | โ |
Fu WeiDirector | โ | โ |
Fu Xi-YongSee Remarks ยท Director | โ | โ |
Lei Ming KylerChief Financial Officer | โ | โ |
Lenz Robert A.Director | โ | โ |
Lin Liwei LorraineGeneral Counsel | โ | โ |
Institutional holders 61
View all โ| Holder | Value | % of shares |
|---|---|---|
| $23.80M | 2.25% | |
| $15.07M | 1.43% | |
| $14.81M | 2.27% | |
| $11.94M | 1.13% | |
| $9.15M | 0.87% | |
| $5.43M | 0.51% | |
| $4.51M | 0.43% | |
| $4.18M | 0.40% | |
| $3.37M | 0.32% | |
| $2.50M | 0.24% |
Activity
Jun 30, 2026View all โ
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares ฮ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Trim | ADR | $-5.90M | -2.4M -28.49% | 6,032,650 2.27% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Exit | ADR | $-3.37M | -846K -100.00% | 0 | low |
| Q3 2025 as of | Barclays PLC 13F manager | Add | ADR | $1.38M | +365K +1202.04% | 395,431 0.15% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | Trim | ADR | $-950.6K | -318K -73.87% | 112,467 0.04% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Add | ADR | $929.3K | +233K +59.05% | 628,923 0.24% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | ADR | $670.1K | +272K | 272,412 0.10% of shares | low |
| Q2 2026 as of | Fiera Capital Corp 13F manager | New | ADR | $615.6K | +316K | 315,681 0.12% of shares | low |
| Q1 2026 as of | ALPS Advisors, Inc. 13F manager | Exit | ADR | $-447.6K | -112K -100.00% | 0 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NBP | ADR | 44975P103 |